The p53 Reactivation Company

Our Company

Aspiring to be the global leader in p53-targeted cancer therapies

Our Pipeline

Pioneering the development of therapeutics to reactivate p53 function

Our Science

Revolutionizing the future of cancer therapy

our clinical trials

Empowering novel cancer treatment options

Investors & Media

Achieving success through high standards of performance and conduct